Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anthony Bergmann Insider Profile
4 Followers
Anthony Bergmann, CFO at Capricor Therapeutics, holds 2.38K shares in Capricor Therapeutics (Ticker: CAPR).
Anthony Bergmann has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Anthony Bergmann's holdings
Insider Roles
CFO
Roles that Anthony Bergmann holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 18, 2016 - Mar 18, 2017
Return:+26.90%
The most profitable trade made by Anthony Bergmann
Anthony Bergmann's Trading History
List of latest transactions for each holding click on a transaction to see Anthony Bergmann's performance on stock
You May Also Like
Anthony Bergmann insider profile FAQ
What is the percentage of profitable transactions made by Anthony Bergmann?
The percentage of profitable transactions made by Anthony Bergmann is ―.
What is the average return per transaction made by Anthony Bergmann?
The average return per transaction made by Anthony Bergmann is ―.
What stocks does Anthony Bergmann hold?
Anthony Bergmann holds: CAPR stocks.
What was Anthony Bergmann’s latest transaction?
Anthony Bergmann latest transaction was an Uninformative Buy of $3.03K.
What was Anthony Bergmann's most profitable transaction?
Anthony Bergmann’s most profitable transaction was an Informative Buy of CAPR stock on March 18, 2016. The return on the trade was 26.90%.
What is Anthony Bergmann's role in Capricor Therapeutics?
Anthony Bergmann's role in Capricor Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.